Comment on "A bibliometric and knowledge-map study on the treatment of hematological malignancies with CAR-T cells from 2012 - 2023".
作者信息
Zhao Hua, Xu Jiayue, Xu Kun, Zhou Yuejun
机构信息
School of Basic Medicine, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
出版信息
Hum Vaccin Immunother. 2024 Dec 31;20(1):2408881. doi: 10.1080/21645515.2024.2408881. Epub 2024 Oct 22.
Abstract
摘要
相似文献
1
Comment on "A bibliometric and knowledge-map study on the treatment of hematological malignancies with CAR-T cells from 2012 - 2023".
Hum Vaccin Immunother. 2024 Dec 31;20(1):2408881. doi: 10.1080/21645515.2024.2408881. Epub 2024 Oct 22.
2
A bibliometric and knowledge-map study on the treatment of hematological malignancies with CAR-T cells from 2012 to 2023.
Hum Vaccin Immunother. 2024 Dec 31;20(1):2371664. doi: 10.1080/21645515.2024.2371664. Epub 2024 Jul 3.
3
A bibliometric and knowledge-map study on the treatment of hematological malignancies with CAR-T cells from 2012 to 2023: A correspondence.
Hum Vaccin Immunother. 2024 Dec 31;20(1):2386223. doi: 10.1080/21645515.2024.2386223. Epub 2024 Aug 6.
4
Response to "A bibliometric and knowledge-map study on the treatment of hematological malignancies with CAR-T cells from 2012 to 2023: A correspondence".
Hum Vaccin Immunother. 2024 Dec 31;20(1):2386225. doi: 10.1080/21645515.2024.2386225. Epub 2024 Aug 7.
5
A Bibliometric and Knowledge-Map Analysis of CAR-T Cells From 2009 to 2021.
Front Immunol. 2022 Mar 18;13:840956. doi: 10.3389/fimmu.2022.840956. eCollection 2022.
6
A bibliometric and knowledge-map study of CAR-T cell-related cytokine release syndrome (CRS) from 2012 to 2023.
Hum Vaccin Immunother. 2023 Dec 15;19(3):2291900. doi: 10.1080/21645515.2023.2291900. Epub 2023 Dec 19.
7
A bibliometric and scientific knowledge-map study of the chimeric antigen receptor (CAR) natural killer (NK) cell-related research from 2010 to 2022.
Front Immunol. 2022 Aug 12;13:969196. doi: 10.3389/fimmu.2022.969196. eCollection 2022.
8
Global research trends in CAR-T cell therapy for solid tumors: A comprehensive visualization and bibliometric study (2012-2023).
Hum Vaccin Immunother. 2024 Dec 31;20(1):2338984. doi: 10.1080/21645515.2024.2338984. Epub 2024 May 2.
9
Bibliometric analysis of research trends and active research areas in chimeric antigen receptor T cell therapy for hematologic malignancies.
Int J Clin Pharm. 2024 Feb;46(1):186-194. doi: 10.1007/s11096-023-01670-1. Epub 2023 Dec 12.
10
The Role of Chimeric Antigen Receptor-T Cell Therapy in the Treatment of Hematological Malignancies: Advantages, Trials, and Tribulations, and the Road Ahead.
Cureus. 2021 Feb 25;13(2):e13552. doi: 10.7759/cureus.13552.
本文引用的文献
1
A bibliometric and knowledge-map study on the treatment of hematological malignancies with CAR-T cells from 2012 to 2023.
Hum Vaccin Immunother. 2024 Dec 31;20(1):2371664. doi: 10.1080/21645515.2024.2371664. Epub 2024 Jul 3.
2
A Bibliometric and Knowledge-Map Analysis of CAR-T Cells From 2009 to 2021.
Front Immunol. 2022 Mar 18;13:840956. doi: 10.3389/fimmu.2022.840956. eCollection 2022.
Zotero 插件